Intellia Therapeutics, Inc. - Common Stock (NTLA)
CUSIP: 45826J105
Q2 2017 13F Holders as of 30 Jun 2017
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 116,932,531
- Total 13F shares
- 16,801,771
- Share change
- +69,234
- Total reported value
- $268,836,976
- Put/Call ratio
- 119%
- Price per share
- $16.00
- Number of holders
- 81
- Value change
- +$2,831,017
- Number of buys
- 55
- Number of sells
- 22
Quarterly Holders Quick Answers
What is CUSIP 45826J105?
CUSIP 45826J105 identifies NTLA - Intellia Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45826J105:
Top shareholders of NTLA - Intellia Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
3.4%
|
4,000,935
|
$56,373,000 | — | 31 Mar 2017 | |
| Atlas Venture Associates IX, LLC |
13F
|
Company |
3.2%
|
3,729,788
|
$52,553,000 | — | 31 Mar 2017 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
2.3%
|
2,662,180
|
$37,510,000 | — | 31 Mar 2017 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.91%
|
1,062,120
|
$14,965,000 | — | 31 Mar 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.81%
|
943,344
|
$13,293,000 | — | 31 Mar 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.77%
|
904,708
|
$12,747,000 | — | 31 Mar 2017 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
0.68%
|
790,527
|
$11,139,000 | — | 31 Mar 2017 | |
| GMT CAPITAL CORP |
13F
|
Company |
0.28%
|
330,533
|
$4,657,000 | — | 31 Mar 2017 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.26%
|
300,000
|
$4,227,000 | — | 31 Mar 2017 | |
| Artal Group S.A. |
13F
|
Company |
0.21%
|
250,000
|
$3,523,000 | — | 31 Mar 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.18%
|
211,525
|
$2,980,000 | — | 31 Mar 2017 | |
| Foresite Capital Management III, LLC |
13F
|
Company |
0.13%
|
150,000
|
$2,114,000 | — | 31 Mar 2017 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
140,000
|
$1,973,000 | — | 31 Mar 2017 | |
| STATE STREET CORP |
13F
|
Company |
0.09%
|
108,435
|
$1,527,000 | — | 31 Mar 2017 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.08%
|
96,153
|
$1,355,000 | — | 31 Mar 2017 | |
| ARK Investment Management LLC |
13F
|
Company |
0.07%
|
79,850
|
$1,125,000 | — | 31 Mar 2017 | |
| PAULSON & CO. INC. |
13F
|
Company |
0.07%
|
78,600
|
$1,107,000 | — | 31 Mar 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.07%
|
76,295
|
$1,075,000 | — | 31 Mar 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
76,095
|
$1,072,000 | — | 31 Mar 2017 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.06%
|
71,842
|
$1,012,000 | — | 31 Mar 2017 | |
| UBS Group AG |
13F
|
Company |
0.05%
|
60,935
|
$859,000 | — | 31 Mar 2017 | |
| Alberta Investment Management Corp |
13F
|
Company |
0.04%
|
50,200
|
$707,000 | — | 31 Mar 2017 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.04%
|
43,086
|
$607,000 | — | 31 Mar 2017 | |
| CLOUGH CAPITAL PARTNERS L P |
13F
|
Company |
0.04%
|
42,600
|
$600,000 | — | 31 Mar 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
40,700
|
$573,000 | — | 31 Mar 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.03%
|
31,676
|
$446,000 | — | 31 Mar 2017 | |
| Airain ltd |
13F
|
Company |
0.02%
|
27,050
|
$381,000 | — | 31 Mar 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.02%
|
26,903
|
$380,000 | — | 31 Mar 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.02%
|
25,881
|
$365,000 | — | 31 Mar 2017 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.02%
|
25,800
|
$364,000 | — | 31 Mar 2017 | |
| Swiss National Bank |
13F
|
Company |
0.02%
|
20,700
|
$292,000 | — | 31 Mar 2017 | |
| ProShare Advisors LLC |
13F
|
Company |
0.02%
|
20,016
|
$282,000 | — | 31 Mar 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.02%
|
19,595
|
$276,000 | — | 31 Mar 2017 | |
| BARCLAYS PLC |
13F
|
Company |
0.02%
|
18,872
|
$267,000 | — | 31 Mar 2017 | |
| ZACKS INVESTMENT MANAGEMENT |
13F
|
Company |
0.02%
|
18,002
|
$254,000 | — | 31 Mar 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
17,840
|
$251,000 | — | 31 Mar 2017 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
14,043
|
$198,000 | — | 31 Mar 2017 | |
| M&T BANK CORP |
13F
|
Company |
0.01%
|
11,516
|
$162,000 | — | 31 Mar 2017 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.01%
|
11,079
|
$156,000 | — | 31 Mar 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
10,945
|
$154,000 | — | 31 Mar 2017 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.01%
|
10,552
|
$149,000 | — | 31 Mar 2017 | |
| A.R.T. Advisors, LLC |
13F
|
Company |
0.01%
|
10,541
|
$148,000 | — | 31 Mar 2017 | |
| Commonwealth Equity Services, Inc |
13F
|
Company |
0.01%
|
10,450
|
$147,000 | — | 31 Mar 2017 | |
| Magnetar Financial LLC |
13F
|
Company |
0.01%
|
10,081
|
$142,000 | — | 31 Mar 2017 | |
| MERIDIAN INVESTMENT COUNSEL INC. |
13F
|
Company |
0.01%
|
10,000
|
$141,000 | — | 31 Mar 2017 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.01%
|
9,698
|
$137,000 | — | 31 Mar 2017 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.01%
|
8,700
|
$123,000 | — | 31 Mar 2017 | |
| IHT Wealth Management, LLC |
13F
|
Company |
0.01%
|
8,280
|
$117,000 | — | 31 Mar 2017 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
7,201
|
$101,000 | — | 31 Mar 2017 | |
| ClariVest Asset Management LLC |
13F
|
Company |
0.01%
|
6,412
|
$90,000 | — | 31 Mar 2017 |
Institutional Holders of Intellia Therapeutics, Inc. - Common Stock (NTLA) as of Q2 2017
As of 30 Jun 2017,
Intellia Therapeutics, Inc. - Common Stock (NTLA) was held by
81 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,801,771 shares.
The largest 10 holders included
Atlas Venture Associates IX, LLC, FMR LLC, ORBIMED ADVISORS LLC, BlackRock Inc., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, Temasek Holdings (Private) Ltd, GRANAHAN INVESTMENT MANAGEMENT INC/MA, Artal Group S.A., and MORGAN STANLEY.
This page lists
81
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2017 vs Q1 2017 Across Filers
Q1 2017 holders
73
Q2 2017 holders
81
Holder diff
8
| Investor | Q1 2017 Shares | Q2 2017 Shares | Share Diff | Share Chg % | Q1 2017 Value $ | Q2 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.